IL6 and type 2 diabetes mellitus: The turbulences of serum cytokines (TNF-α, IL-1β, IL-4, and IL-6) in T2D rats were significantly altered by NXT treatment, suggesting that NXT could mitigate low-grade inflammation in T2D.